Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 34, Issue 1, 2014, Pages 136-145

  Corsini, Michela ^a   Moroni, Emanuela ^a   Ravelli, Cosetta ^a   Andrés, Germán ^b   Grillo, Elisabetta ^a   Ali, Imran H ^c   Brazil, Derek P ^c   Presta, Marco ^a   Mitola, Stefania ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Cyclic AMP response element binding protein

Indexed keywords

CELL ADHESION MOLECULE; CXCL1 CHEMOKINE; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; GREMLIN; HYDROCORTISONE; INTERCELLULAR ADHESION MOLECULE 1; LIGAND; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; MUTANT PROTEIN; REACTIVE OXYGEN METABOLITE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL MEMBRANE PERMEABILITY; CELL MOTILITY; CELL STIMULATION; CELLS; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; EMBRYO; ENDOTHELIUM CELL; GENE TRANSLOCATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; UPREGULATION;

EID: 84891831460     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.113.302517     Document Type: Article

References (57)

1. Jackson JR, Seed MP, Kircher CH, Willoughby DA, Winkler JD. The codependence of angiogenesis and chronic inflammation. FASEB J. 1997;11:457-465
2. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407:249-257
3. Schmid MC, Varner JA. Myeloid cell trafficking and tumor angiogenesis. Cancer Lett. 2007;250:1-8
4. Zijlstra A, Seandel M, Kupriyanova TA, Partridge JJ, Madsen MA, Hahn-Dantona EA, Quigley JP, Deryugina EI. Proangiogenic role of neutrophil-like inflammatory heterophils during neovascularization induced by growth factors and human tumor cells. Blood. 2006;107:317-327
5. Voronov E, Shouval DS, Krelin Y, Cagnano E, Benharroch D, Iwakura Y, Dinarello CA, Apte RN. IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci U S A. 2003;100:2645-2650
6. Naldini A, Leali D, Pucci A, Morena E, Carraro F, Nico B, Ribatti D, Presta M. Cutting edge: IL-1beta mediates the proangiogenic activity of osteopontin-Activated human monocytes. J Immunol. 2006;177:4267-4270
7. Leali D, Dell'Era P, Stabile H, Sennino B, Chambers AF, Naldini A, Sozzani S, Nico B, Ribatti D, Presta M. Osteopontin (Eta-1) and fibroblast growth factor-2 cross-Talk in angiogenesis. J Immunol. 2003;171:1085-1093
8. Aplin AC, Gelati M, Fogel E, Carnevale E, Nicosia RF. Angiopoietin-1 and vascular endothelial growth factor induce expression of inflammatory cytokines before angiogenesis. Physiol Genomics. 2006;27:20-28
9. Angelo LS, Kurzrock R. Vascular endothelial growth factor and its relationship to inflammatory mediators. Clin Cancer Res. 2007;13:2825-2830
10. Andrés G, Leali D, Mitola S, Coltrini D, Camozzi M, Corsini M, Belleri M, Hirsch E, Schwendener RA, Christofori G, Alcamí A, Presta M. A proinflammatory signature mediates FGF2-induced angiogenesis. J Cell Mol Med. 2009;13(8B):2083-2108
11. Ichiki T. Role of cAMP response element binding protein in cardiovascular remodeling: Good, bad, or both? Arterioscler Thromb Vasc Biol. 2006;26:449-455
12. Mayo LD, Kessler KM, Pincheira R, Warren RS, Donner DB. Vascular endothelial cell growth factor activates CRE-binding protein by signaling through the KDR receptor tyrosine kinase. J Biol Chem. 2001;276:25184-25189
13. Jeon SH, Chae BC, Kim HA, Seo GY, Seo DW, Chun GT, Yie SW, Eom SH, Kim PH. The PKA/CREB pathway is closely involved in VEGF expression in mouse macrophages. Mol Cells. 2007;23:23-29
14. Morishita K, Johnson DE, Williams LT. A novel promoter for vascular endothelial growth factor receptor (flt-1) that confers endothelial-specific gene expression. J Biol Chem. 1995;270:27948-27953
15. Leonard MO, Howell K, Madden SF, Costello CM, Higgins DG, Taylor CT, McLoughlin P. Hypoxia selectively activates the CREB family of transcription factors in the in vivo lung. Am J Respir Crit Care Med. 2008;178:977-983
16. Abramovitch R, Tavor E, Jacob-Hirsch J, Zeira E, Amariglio N, Pappo O, Rechavi G, Galun E, Honigman A. A pivotal role of cyclic AMPresponsive element binding protein in tumor progression. Cancer Res. 2004;64:1338-1346
17. Zhao D, Desai S, Zeng H. VEGF stimulates PKD-mediated CREBdependent orphan nuclear receptor Nurr1 expression: Role in VEGFinduced angiogenesis. Int J Cancer. 2011;128:2602-2612
18. Kottakis F, Polytarchou C, Foltopoulou P, Sanidas I, Kampranis SC, Tsichlis PN. FGF-2 regulates cell proliferation, migration, and angiogenesis through an NDY1/KDM2B-miR-101-EZH2 pathway. Mol Cell. 2011;43:285-298
19. Hoot KE, Oka M, Han G, Bottinger E, Zhang Q, Wang XJ. HGF upregulation contributes to angiogenesis in mice with keratinocyte-specific Smad2 deletion. J Clin Invest. 2010;120:3606-3616
20. Schroer K, Zhu Y, Saunders MA, Deng WG, Xu XM, Meyer-Kirchrath J, Wu KK. Obligatory role of cyclic adenosine monophosphate response element in cyclooxygenase-2 promoter induction and feedback regulation by inflammatory mediators. Circulation. 2002;105:2760-2765
21. Scoditti E, Massaro M, Carluccio MA, Distante A, Storelli C, De Caterina R. PPARgamma agonists inhibit angiogenesis by suppressing PKCalphaand CREB-mediated COX-2 expression in the human endothelium. Cardiovasc Res. 2010;86:302-310
22. Pearce JJ, Penny G, Rossant J. A mouse cerberus/Dan-related gene family. Dev Biol. 1999;209:98-110
23. Vitt UA, Hsu SY, Hsueh AJ. Evolution and classification of cystine knotcontaining hormones and related extracellular signaling molecules. Mol Endocrinol. 2001;15:681-694
24. Murphy M, McMahon R, Lappin DW, Brady HR. Gremlins: Is this what renal fibrogenesis has come tÖ Exp Nephrol. 2002;10:241-244
25. Namkoong H, Shin SM, Kim HK, Ha SA, Cho GW, Hur SY, Kim TE, Kim JW. The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein. BMC Cancer. 2006;6:74
26. Sneddon JB, Zhen HH, Montgomery K, van de Rijn M, Tward AD, West R, Gladstone H, Chang HY, Morganroth GS, Oro AE, Brown PO. Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-Associated stromal cells and can promote tumor cell proliferation. Proc Natl Acad Sci U S A. 2006;103:14842-14847
27. Stabile H, Mitola S, Moroni E, Belleri M, Nicoli S, Coltrini D, Peri F, Pessi A, Orsatti L, Talamo F, Castronovo V, Waltregny D, Cotelli F, Ribatti D, Presta M. Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. Blood. 2007;109:1834-1840
28. Balemans W, Van Hul W. Extracellular regulation of BMP signaling in vertebrates: A cocktail of modulators. Dev Biol. 2002;250:231-250
29. Mitola S, Moroni E, Ravelli C, Andres G, Belleri M, Presta M. Angiopoietin-1 mediates the proangiogenic activity of the bone morphogenic protein antagonist Drm. Blood. 2008;112:1154-1157
30. Mitola S, Ravelli C, Moroni E, Salvi V, Leali D, Ballmer-Hofer K, Zammataro L, Presta M. Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2. Blood. 2010;116:3677-3680
31. Maiolo D, Mitola S, Leali D, Oliviero G, Ravelli C, Bugatti A, Depero LE, Presta M, Bergese P. Role of nanomechanics in canonical and noncanonical pro-Angiogenic ligand/VEGF receptor-2 activation. J Am Chem Soc. 2012;134:14573-14579
32. Chiodelli P, Mitola S, Ravelli C, Oreste P, Rusnati M, Presta M. Heparan sulfate proteoglycans mediate the angiogenic activity of the vascular endothelial growth factor receptor-2 agonist gremlin. Arterioscler Thromb Vasc Biol. 2011;31:e116-e127
33. Ravelli C, Mitola S, Corsini M, Presta M. Involvement of alphavbeta3 integrin in gremlin-induced angiogenesis. Angiogenesis. 2013;16:235-243
34. Shaywitz AJ, Greenberg ME. CREB: A stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem. 1999;68:821-861
35. Cui H, Okamoto Y, Yoshioka K, et al. Sphingosine-1-phosphate receptor 2 protects against anaphylactic shock through suppression of endothelial nitric oxide synthase in mice. J Allergy Clin Immunol. 2013
36. Sun Z, Li X, Massena S, et al. VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd. J Exp Med. 2012;209:1363-1377
37. Ono H, Ichiki T, Ohtsubo H, Fukuyama K, Imayama I, Iino N, Masuda S, Hashiguchi Y, Takeshita A, Sunagawa K. CAMP-response elementbinding protein mediates tumor necrosis factor-Alpha-induced vascular cell adhesion molecule-1 expression in endothelial cells. Hypertens Res. 2006;29:39-47
38. Yang L, Kowalski JR, Yacono P, Bajmoczi M, Shaw SK, Froio RM, Golan DE, Thomas SM, Luscinskas FW. Endothelial cell cortactin coordinates intercellular adhesion molecule-1 clustering and actin cytoskeleton remodeling during polymorphonuclear leukocyte adhesion and transmigration. J Immunol. 2006;177:6440-6449
39. Wittchen ES. Endothelial signaling in paracellular and transcellular leukocyte transmigration. Front Biosci (Landmark Ed). 2009;14: 2522-2545
40. Hadad N, Tuval L, Elgazar-Carmom V, Levy R. Endothelial ICAM-1 protein induction is regulated by cytosolic phospholipase A2alpha via both NF-kappaB and CREB transcription factors. J Immunol. 2011;186:1816-1827
41. Parry CM, Simas JP, Smith VP, Stewart CA, Minson AC, Efstathiou S, Alcami A. A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J Exp Med. 2000;191:573-578
42. Li BX, Yamanaka K, Xiao X. Structure-Activity relationship studies of naphthol AS-E and its derivatives as anticancer agents by inhibiting CREBmediated gene transcription. Bioorg Med Chem. 2012;20:6811-6820
43. Coltrini D, Di Salle E, Ronca R, Belleri M, Testini C, Presta M. Matrigel plug assay: Evaluation of the angiogenic response by reverse transcriptionquantitative PCR. Angiogenesis. 2013;16:469-477
44. Kiefer F, Siekmann AF. The role of chemokines and their receptors in angiogenesis. Cell Mol Life Sci. 2011;68:2811-2830
45. Presta M, Dell'Era P, Mitola S, Moroni E, Ronca R, Rusnati M. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev. 2005;16:159-178
46. Claesson-Welsh L, Welsh M. VEGFA and tumour angiogenesis. J Intern Med. 2013;273:114-127
47. Durán WN, Breslin JW, Sánchez FA. The NO cascade, eNOS location, and microvascular permeability. Cardiovasc Res. 2010;87:254-261
48. De Martin R, Hoeth M, Hofer-Warbinek R, Schmid JA. The transcription factor NF-kappa B and the regulation of vascular cell function. Arterioscler Thromb Vasc Biol. 2000;20:E83-E88
49. Wen AY, Sakamoto KM, Miller LS. The role of the transcription factor CREB in immune function. J Immunol. 2010;185:6413-6419
50. Mitola S, Moroni E, Ravelli C, Andres G, Belleri M, Presta M. Angiopoietin-1 mediates the proangiogenic activity of the bone morphogenic protein antagonist Drm. Blood. 2008;112:1154-1157
51. Li Y, Wang Z, Wang S, Zhao J, Zhang J, Huang Y. Gremlin-mediated decrease in bone morphogenetic protein signaling promotes aristolochic acid-induced epithelial-To-mesenchymal transition (EMT) in HK-2 cells. Toxicology. 2012;297:68-75
52. Cahill E, Costello CM, Rowan SC, Harkin S, Howell K, Leonard MO, Southwood M, Cummins EP, Fitzpatrick SF, Taylor CT, Morrell NW, Martin F, McLoughlin P. Gremlin plays a key role in the pathogenesis of pulmonary hypertension. Circulation. 2012;125:920-930
53. Li G, Li Y, Liu S, et al. Gremlin aggravates hyperglycemia-induced podocyte injury by a TGFbeta/smad dependent signaling pathway. J Cell Biochem. 2013;114:2101-2113
54. Costello CM, Cahill E, Martin F, Gaine S, McLoughlin P. Role of gremlin in the lung: Development and disease. Am J Respir Cell Mol Biol. 2010;42:517-523
55. Roxburgh SA, Kattla JJ, Curran SP, O'Meara YM, Pollock CA, Goldschmeding R, Godson C, Martin F, Brazil DP. Allelic depletion of grem1 attenuates diabetic kidney disease. Diabetes. 2009;58:1641-1650
56. Müller I, Schönberger T, Schneider M, et al. Gremlin-1 Is an Inhibitor of Macrophage Migration Inhibitory Factor and Attenuates Atherosclerotic Plaque Growth in ApoE-/-Mice. J Biol Chem. 2013;288:31635-31645
57. Phani S, Jablonski M, Pelta-Heller J, Cai J, Iacovitti L. Gremlin is a novel VTA derived neuroprotective factor for dopamine neurons. Brain Res. 2013;1500:88-98